Publications by authors named "Thilo Zander"

Claim this Profile
U
Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland.
Martina Bertschinger, Holger W Auner, Veronika Ballova, Carmen De Ramon Ortiz, Christoph Driessen, Thilo Zander

Swiss Med Wkly· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.
Eva Kimby, Sämi Schär, Maria Cristina Pirosa, Anna Vanazzi, Ulrich M Mey, Thilo Zander

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13).
Urban Novak, Martin Fehr, Sämi Schär, Martin Dreyling, Christian Schmidt, Thilo Zander

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial.
Thilo Zander, Thomas Pabst, Sämi Schär, Stefan Aebi, Ulrich Mey

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia.
Alexander D Heini, Philipp Beck, Ulrike Bacher, Katja Seipel, Thilo Zander

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blinatumomab in Relapsed/Refractory Burkitt Lymphoma.
Jeanne Bohler, Ulrike Bacher, Yara Banz, Raphael Stadelmann, Michael Medinger, Thilo Zander

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial.
Sarah Farag, Ulrike Bacher, Barbara Jeker, Myriam Legros, Gaelle Rhyner, Thilo Zander

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satraplatin Demonstrates High Cytotoxic Activity Against Genetically Defined Lymphoid Malignancies.
Thilo Zander, Jia Xue, Gabriel Markson, Felix Dahm, Christoph Renner

Anticancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial response to dabrafenib and trametinib in relapsed BRAF V600E-Mutated multiple myeloma and possible mechanisms of resistance.
Tina Ernst, Stefan Aebi, Andrea Zander, Thilo Zander

BMJ Case Rep· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma.
Pieter Sonneveld, Meletios A Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Thilo Zander

J Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Michele Cavo, Francesca Gay, Meral Beksac, Lucia Pantani, Maria Teresa Petrucci, Thilo Zander

Lancet Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.
Irene Prediletto, Sarah A Farag, Ulrike Bacher, Barbara Jeker, Behrouz Mansouri Taleghani, Thilo Zander

Bone Marrow Transplant· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J M Mey, Thilo Zander

Blood· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Panagiotis Samaras, Mario Bargetzi, Daniel C Betticher, Christoph Driessen, Michel A Duchosal, Thilo Zander

Swiss Med Wkly· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma.
Isabel G Amsler, Barbara Jeker, Behrouz Mansouri Taleghani, Ulrike Bacher, Daniel Betticher, Thilo Zander

Leuk Lymphoma· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of follicular lymphoma: an update.
Mario Bargetzi, Reto Baumann, Sergio Cogliatti, Pierre-Yves Dietrich, Michel Duchosal, Thilo Zander

Swiss Med Wkly· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma.
Christoph Driessen, Rouven Müller, Urban Novak, Nathan Cantoni, Daniel Betticher, Thilo Zander

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft.
Ursina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, Ulrike Bacher, Urban Novak, Thilo Zander

Hematol Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.
Oliver Gautschi, Sacha I Rothschild, Qiyu Li, Klazien Matter-Walstra, Alfred Zippelius, Thilo Zander

Clin Lung Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients.
Stefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, Gabriela M Baerlocher, Kurt Leibundgut, Thilo Zander

Ann Hematol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Pembrolizumab in a Patient with Relapsing Thymoma.
Thilo Zander, Stefan Aebi, Anna Christina Rast, Andrea Zander, Ralph Winterhalder

J Thorac Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.
Panagiotis Samaras, Mario Bargetzi, Daniel C Betticher, Michel A Duchosal, Dominik Heim, Thilo Zander

Swiss Med Wkly· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient with lung adenocarcinoma and RET fusion treated with vandetanib.
Oliver Gautschi, Thilo Zander, Franziska Aebersold Keller, Klaus Strobel, Astrid Hirschmann

J Thorac Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical value of echocardiography and acoustic cardiography to monitor patients undergoing anthracycline chemotherapy.
Stefan Toggweiler, Yvonne Odermatt, Andreas Brauchlin, Thilo Zander, Andrea Müller

Clin Cardiol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.
Silvia Hofer, Katarzyna Elandt, Richard Greil, Andreas F Hottinger, Urs Huber, Thilo Zander

Acta Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis